Community Pharmacist-led Telephone Follow-up Enabled Close Management of Everolimus-induced Adverse Events in an Outpatient with Metastatic Breast Cancer

Overview

Journal Can Pharm J (Ott)

Specialty Pharmacology

Date 2017 Nov 11

PMID 29123595

Citations 2

Authors

Satoshi Yokoyama

Satoko Yajima

Chihiro Sakai

Shuji Yamashita

Yoshihiro Noguchi

Yoko Ino

Kazuhiro Iguchi

Hitomi Teramachi

Affiliations

Soon will be listed here.

Citing Articles

Pharmacists' knowledge, attitudes, beliefs, and barriers toward breast cancer health promotion: a cross-sectional study in the Palestinian territories.

Shawahna R, Awawdeh H BMC Health Serv Res. 2021; 21(1):429.

PMID: 33952277 PMC: 8101222. DOI: 10.1186/s12913-021-06458-5.

Oncology pharmacist contributions to treatment with oral anticancer agents in a Japanese community pharmacy setting.

Yokoyama S, Yajima S, Shimauchi A, Sakai C, Yamashita S, Noguchi Y Can Pharm J (Ott). 2018; 151(6):377-382.

PMID: 30559912 PMC: 6293393. DOI: 10.1177/1715163518802865.

References

Baselga J, Campone M, Piccart M, Burris 3rd H, Rugo H, Sahmoud T . Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer. N Engl J Med. 2011; 366(6):520-9. PMC: 5705195. DOI: 10.1056/NEJMoa1109653. View

Nesari M, Zakerimoghadam M, Rajab A, Bassampour S, Faghihzadeh S . Effect of telephone follow-up on adherence to a diabetes therapeutic regimen. Jpn J Nurs Sci. 2010; 7(2):121-8. DOI: 10.1111/j.1742-7924.2010.00146.x. View

Van Rooij T, Rix S, Marsh S . AntiC: A practice tool for the safe use of oral chemotherapeutics by community and hospital pharmacists. Can Pharm J (Ott). 2015; 148(3):118-24. PMC: 4483757. DOI: 10.1177/1715163515578454. View

Peterson D, OShaughnessy J, Rugo H, Elad S, Schubert M, Viet C . Oral mucosal injury caused by mammalian target of rapamycin inhibitors: emerging perspectives on pathobiology and impact on clinical practice. Cancer Med. 2016; 5(8):1897-907. PMC: 4971919. DOI: 10.1002/cam4.761. View

Leahy M, Krishnasamy M, Herschtal A, Bressel M, Dryden T, Tai K . Satisfaction with nurse-led telephone follow up for low to intermediate risk prostate cancer patients treated with radical radiotherapy. A comparative study. Eur J Oncol Nurs. 2012; 17(2):162-9. DOI: 10.1016/j.ejon.2012.04.003. View

Lloyd A, Nafees B, Narewska J, Dewilde S, Watkins J . Health state utilities for metastatic breast cancer. Br J Cancer. 2006; 95(6):683-90. PMC: 2360509. DOI: 10.1038/sj.bjc.6603326. View

Noguchi S, Masuda N, Iwata H, Mukai H, Horiguchi J, Puttawibul P . Efficacy of everolimus with exemestane versus exemestane alone in Asian patients with HER2-negative, hormone-receptor-positive breast cancer in BOLERO-2. Breast Cancer. 2013; 21(6):703-14. PMC: 4210660. DOI: 10.1007/s12282-013-0444-8. View

Hortobagyi G . Everolimus plus exemestane for the treatment of advanced breast cancer: a review of subanalyses from BOLERO-2. Neoplasia. 2015; 17(3):279-88. PMC: 4372651. DOI: 10.1016/j.neo.2015.01.005. View

Clari M, Frigerio S, Ricceri F, Pici A, Alvaro R, Dimonte V . Follow-up telephone calls to patients discharged after undergoing orthopaedic surgery: double-blind, randomised controlled trial of efficacy. J Clin Nurs. 2015; 24(19-20):2736-44. DOI: 10.1111/jocn.12795. View

10.

Kimura M, Go M, Iwai M, Usami E, Teramachi H, Yoshimura T . Evaluation of the role and usefulness of a pharmacist outpatient service for patients undergoing monotherapy with oral anti-cancer agents. J Oncol Pharm Pract. 2016; 23(6):413-421. DOI: 10.1177/1078155216655473. View

11.

Broadfield L, Shaheen P, Rogez M, Jamieson K, McCallum M . Guidelines for outpatient cancer care by community pharmacists. Can Pharm J (Ott). 2017; 150(1):24-31. PMC: 5330421. DOI: 10.1177/1715163516680009. View

12.

Rugo H, Pritchard K, Gnant M, Noguchi S, Piccart M, Hortobagyi G . Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2. Ann Oncol. 2014; 25(4):808-815. PMC: 3969554. DOI: 10.1093/annonc/mdu009. View

13.

Najafi S, Shaabani M, Momennassab M, Aghasadeghi K . The Nurse-Led Telephone Follow-Up on Medication and Dietary Adherence among Patients after Myocardial Infarction: A Randomized Controlled Clinical Trial. Int J Community Based Nurs Midwifery. 2016; 4(3):199-208. PMC: 4925999. View